首页> 外文期刊>Journal of Indian Society of Periodontology >Efficacy of Ayurvedic drugs as compared to chlorhexidine in management of chronic periodontitis: A randomized controlled clinical study
【24h】

Efficacy of Ayurvedic drugs as compared to chlorhexidine in management of chronic periodontitis: A randomized controlled clinical study

机译:与氯己定相比,阿育吠陀药物治疗慢性牙周炎的有效性:一项随机对照临床研究

获取原文
获取外文期刊封面目录资料

摘要

Background: In India, Ayurveda is considered to be more effective and cheaper than modern medicine. Ayurvedic literature shows its use in treating oral diseases also. However, their effectiveness, in comparison with the allopathic mode of management, has not been assessed previously. The aim of this randomized controlled clinical trial was to compare the efficacy of ayurvedic drugs over chlorhexidine in treating chronic periodontitis. Materials and Methods: Four hundred and eight participants, in the age group 20–49 years, suffering from mild-to-moderate chronic periodontitis were included in this study. Community periodontal index for treatment needs (CPITN) score was recorded, and oral prophylaxis was done for each patient. They were then randomly divided into 6 groups: control group (I), chlorhexidine (II), Khadiradi vati (III), Dashansanskar churana (IV), Neem (V), and Apamarga (VI); based on the drugs used by patients for the maintenance of oral hygiene after oral prophylaxis. Patients were recalled at 1 week, 1 month, and 3 months after oral prophylaxis. CPITN score was re-recorded for each patient at each follow-up. Reduction in CPITN score indicated improvement in the periodontal health. Observations were statistically analyzed using univariate ANOVA and P value was set at Results: Improvement in CPITN scores in 6 groups was as follows: I – 42.0%, II – 76.37%, III – 82.03%, IV – 83.46%, V – 78.8%, and VI – 29.9%. Higher mean percentage improvement was seen when patients used these drugs for 3 months as compared to 1 month. Conclusion: Dashansanskar churana and Khadiradi vati showed better results than chlorhexidine and were found to be superior in managing mild-to-moderate cases of chronic periodontitis.
机译:背景:在印度,阿育吠陀被认为比现代医学更有效,更便宜。阿育吠陀文献显示其也可用于治疗口腔疾病。但是,与同种疗法的管理模式相比,它们的有效性尚未得到评估。这项随机对照临床试验的目的是比较阿育吠陀药物相对于氯己定在治疗慢性牙周炎中的功效。资料与方法:这项研究包括20-49岁年龄段的408名参与者,他们患有轻度至中度的慢性牙周炎。记录社区需要治疗的牙周指数(CPITN)分数,并对每位患者进行口服预防。然后将他们随机分为6组:对照组(I),洗必泰(II),卡迪拉迪瓦蒂(III),Dashansanskar churana(IV),Neem(V)和Apamarga(VI);基于患者预防口腔疾病后维持口腔卫生的药物。口服预防后1周,1个月和3个月召回患者。在每次随访中重新记录每位患者的CPITN分数。 CPITN得分降低表明牙周健康得到改善。使用单变量方差分析对观察结果进行统计分析,将P值设置为结果:6组的CPITN得分改善如下:I – 42.0%,II – 76.37%,III – 82.03%,IV – 83.46%,V – 78.8%和VI – 29.9%。当患者使用这些药物3个月时,与1个月相比,平均改善率更高。结论:Dashansanskar churana和Khadiradi vati比洗必泰显示出更好的效果,并被发现在治疗轻度至中度慢性牙周炎方面更胜一筹。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号